author-photo

J. Huober

Kantonsspital St. Gallen
University of Tübingen

94

Papers

2053

Citations

Citation Trend

Filter By

Papers (69) Sort By

Journal Conference Others

Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
288PDPERNETTA: A non-comparative randomized open label phase II trial of pertuzumab (P) + trastuzumab (T) with or without chemotherapy both followed by T-DM1 in case of progression, in patients with HER2-positive metastatic breast cancer (MBC): (SAKK 22/10 / UNICANCER UC-0140/1207)

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Therapeutische Grundlagen in der gynäkologischen Onkologie

2018
Show All
- Source
- Cite
- Save
Citations (0)
Endokrine Therapie beim metastasierten Mammakarzinom

2017 Gynakologe
Show All
- Source
- Cite
- Save
Citations (0)
Erstbehandlung von Patientinnen mit primärem Mammakarzinom: Evidenz, Kontroversen, Konsens

2017
Show All
- Source
- Cite
- Save
Citations (1)
3. Gonadotoxizität zytostatischer Therapien

2017
Show All
- Source
- Cite
- Save
Citations (0)
Relationship Between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer

2016 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (111)
15. International St.Gallen Breast Cancer Conference – Zum 2. Mal in Wien

2016
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2− early breast cancer: WSG-AGO EC-Doc Trial

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Modeling bone mineral density (BMD) evolution in postmenopausal patients treated by letrozole (L), tamoxifen (T), and sequences of T and L (SAKK 21/07)

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)